Style | Citing Format |
---|---|
MLA | Shahhosseini A, et al.. "High Levels of Histone H3 K27 Acetylation and Tri-Methylation Are Associated With Shorter Survival in Oral Squamous Cell Carcinoma Patients." BioMedicine (Taiwan), vol. 13, no. 1, 2023, pp. 22-38. |
APA | Shahhosseini A, Bourovaflin E, Derakhshan S, Aminishakib P, Goudarzi A (2023). High Levels of Histone H3 K27 Acetylation and Tri-Methylation Are Associated With Shorter Survival in Oral Squamous Cell Carcinoma Patients. BioMedicine (Taiwan), 13(1), 22-38. |
Chicago | Shahhosseini A, Bourovaflin E, Derakhshan S, Aminishakib P, Goudarzi A. "High Levels of Histone H3 K27 Acetylation and Tri-Methylation Are Associated With Shorter Survival in Oral Squamous Cell Carcinoma Patients." BioMedicine (Taiwan) 13, no. 1 (2023): 22-38. |
Harvard | Shahhosseini A et al. (2023) 'High Levels of Histone H3 K27 Acetylation and Tri-Methylation Are Associated With Shorter Survival in Oral Squamous Cell Carcinoma Patients', BioMedicine (Taiwan), 13(1), pp. 22-38. |
Vancouver | Shahhosseini A, Bourovaflin E, Derakhshan S, Aminishakib P, Goudarzi A. High Levels of Histone H3 K27 Acetylation and Tri-Methylation Are Associated With Shorter Survival in Oral Squamous Cell Carcinoma Patients. BioMedicine (Taiwan). 2023;13(1):22-38. |
BibTex | @article{ author = {Shahhosseini A and Bourovaflin E and Derakhshan S and Aminishakib P and Goudarzi A}, title = {High Levels of Histone H3 K27 Acetylation and Tri-Methylation Are Associated With Shorter Survival in Oral Squamous Cell Carcinoma Patients}, journal = {BioMedicine (Taiwan)}, volume = {13}, number = {1}, pages = {22-38}, year = {2023} } |
RIS | TY - JOUR AU - Shahhosseini A AU - Bourovaflin E AU - Derakhshan S AU - Aminishakib P AU - Goudarzi A TI - High Levels of Histone H3 K27 Acetylation and Tri-Methylation Are Associated With Shorter Survival in Oral Squamous Cell Carcinoma Patients JO - BioMedicine (Taiwan) VL - 13 IS - 1 SP - 22 EP - 38 PY - 2023 ER - |